Sentiment:
LG never promised DI that the company would not be sold out. As LP and LG have said, that for the right offer anything is on the table, now or in the future. Having said that, I doubt that big P or any other suitor would make a BO offer satisfactory to LP even if top line is impressive. I think they will wait at least until approval by the FDA which I think is the most critical RA for NWBO. I don't see approval coming until at perhaps 2021. So I think DI's job is secure at least until then as there will very likely be no BO in the interim. Like anybody else who has a significant stake in NWBO, even DI would be very happy with a nice buyout, even if his job were somehow to disappear because of it.
Hopefully, NWBO will announce impressive top line results at ASCO. If so, we might see a nice bump in the share price from present levels. Anything less than that and continued silence, watch out below. I think a multiplier effect of 4x~5x is possible with the share price in the range of $1.20~$1.50. More importantly, I believe this range is sustainable and moving toward approvals, I think the pps could eventually rise over the $2.00 level despite MMs' manipulative attempts. With broad FDA approvals, I think the pps could double from those levels, but the stock will be affected by commercialisation doubts and management credibility issues keeping a lid on the stock. I think that with NWBO, the market is "from Missouri" and that it will wait to see actual revenue and profit results as well as rate of market penetration. I believe that share prices in the $10~$30 zone as some posters have opined are Alice-in- Wonderland fantasies. I would bet this never happens or is very far in the future. My own personal view is that I would thank the Lord for a Fatima/Lourdes miracle if the pps eventually hit $4~$5 although most probably, I would be long gone by then. JMHO.
